Home » Topics » Financings

Financings
RSS

Jiuyuan Gene raises HKD$485M in Hong Kong IPO

Dec. 3, 2024

Hangzhou Jiuyuan Gene Engineering Co. Ltd. raised HKD$485.4 million (US$62.38 million) in a November 28 IPO on the main board of the Hong Kong Stock Exchange (HKEX:2566).

Financings for Dec. 2, 2024

Dec. 2, 2024

Biopharmas raising money in public or private financings, including: Secretome, Transcode.

Financings for December 2, 2024

Dec. 2, 2024

Med-tech firms raising money in public or private financings, including: Photonicare, Sequana Medical.

Jiuyuan Gene raises HKD$485M in Hong Kong IPO

Dec. 2, 2024

By Tamra Sami

Hangzhou Jiuyuan Gene Engineering Co. Ltd. raised HKD$485.4 million (US$62.38 million) in a November 28 IPO on the main board of the Hong Kong Stock Exchange (HKEX:2566).

Financings for Nov. 27, 2024

Nov. 27, 2024

Biopharmas raising money in public or private financings, including: 35Pharma, Replimune.

Financings for November 27, 2024

Nov. 27, 2024

Med-tech firms raising money in public or private financings, including: Lifecore.

Financings for Nov. 26, 2024

Nov. 26, 2024

Biopharmas raising money in public or private financings, including: Adcendo, Doron, Eyenovia, Kanglin.

Financings for November 26, 2024

Nov. 26, 2024

Med-tech firms raising money in public or private financings, including: Autonomix, Cradle, Eyenovia, Neoplas.

Financings for November 26, 2024

Nov. 26, 2024

Biopharmas in Asia-Pacific raising money in public or private financings: C-Ray Therapeutics.

Financings for Nov. 25, 2024

Nov. 25, 2024

Biopharmas raising money in public or private financings, including: Aptose, Autoimmunity, Biofrontera, Bioxcel, Enveda, Oncoverity.

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...

Financings RSS

Financings
RSS